bioMérieux

About bioMérieux

bioMérieux is a global leader in the field of in vitro diagnostics, dedicated to improving public health through innovative solutions. Founded in 1963, the company has established itself as a pioneer in the development of diagnostic tests that help detect infectious diseases and monitor health conditions.

With a strong commitment to research and development, bioMérieux invests significantly in advancing technologies that enhance laboratory efficiency and accuracy. The company’s product portfolio includes a wide range of diagnostic solutions for clinical microbiology, immunoassays, and molecular biology.

bioMérieux operates in over 150 countries, providing healthcare professionals with essential tools to make informed decisions. Their mission is to provide reliable and timely diagnostic information that can lead to better patient outcomes.

The company is also focused on sustainability and corporate social responsibility, striving to minimize its environmental impact while contributing to global health initiatives. bioMérieux collaborates with various stakeholders, including healthcare providers, researchers, and public health organizations, to address pressing health challenges.

In addition to its diagnostic products, bioMérieux offers comprehensive support services, ensuring that laboratories are equipped with the necessary training and resources to utilize their technologies effectively.

As a trusted partner in healthcare, bioMérieux continues to push the boundaries of innovation, aiming to transform the future of diagnostics and improve the quality of life for patients worldwide.